Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has received an approval for the Scheme of Arrangement among Sun Pharma Global FZE (indirect wholly owned subsidiary of the Company) and the company and their respective members and creditors, for demerger of unbranded generic pharmaceutical undertaking of Sun Pharma Global FZE to the Company. The Board of Directors of the Company at their meeting held on November 14, 2017, approved the same on the recommendation of the Audit Committee.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.